| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 336 | 1.676 | 1.035 | 1.257 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 25.389 | 1.676 | 1.035 | 1.257 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 27.115 | 9.040 | 732 | 1.657 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.725 | -7.364 | 303 | -400 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.745 | -7.400 | 272 | -438 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Molecule Apartments Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 626 | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.113 | 100 | 954 | 1.535 | 1.395 | 1.369 | 1.338 | 1.343 | 1.339 | 1.327 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 182 | 87 | 85 | 84 | 82 | 81 | 79 | 79 | 79 | 75 |
| Cash | 6.931 | 13 | 869 | 1.451 | 1.313 | 1.288 | 1.260 | 1.264 | 1.260 | 1.253 |
| Shareholders Funds | -1.700 | -9.083 | -8.657 | -8.936 | -8.763 | -8.597 | -8.406 | -8.432 | -8.407 | -8.360 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.439 | 9.228 | 9.611 | 10.471 | 10.158 | 9.966 | 9.745 | 9.775 | 9.745 | 9.687 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Molecule Apartments Srl